On February 25, 2022, Ivana Magovcevic-Liebisch notified Applied Genetic Technologies Corporation that she was resigning from board of directors and each committee of which she was a member effective March 9, 2022. Dr. Magovcevic-Liebisch's decision to resign from board of directors is due to increased commitments as a result of her role as the Chief Executive Officer of a publicly traded company and was not the result of any disagreement with the company on any matter related to operations, policies or practices.
Applied Genetic Technologies Corporation
Equities
AGTC
US03820J1007
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |